Cargando…

Computing Drug-Drug Similarity from Patient-Centric Data

In modern biology and medicine, drug-drug similarity is a major task with various applications in pharmaceutical drug development. Various direct and indirect sources of evidence obtained from drug-centric data such as side effects, drug interactions, biological targets, and chemical structures are...

Descripción completa

Detalles Bibliográficos
Autor principal: Asiri, Yousef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952733/
https://www.ncbi.nlm.nih.gov/pubmed/36829676
http://dx.doi.org/10.3390/bioengineering10020182
_version_ 1784893705133490176
author Asiri, Yousef
author_facet Asiri, Yousef
author_sort Asiri, Yousef
collection PubMed
description In modern biology and medicine, drug-drug similarity is a major task with various applications in pharmaceutical drug development. Various direct and indirect sources of evidence obtained from drug-centric data such as side effects, drug interactions, biological targets, and chemical structures are used in the current methods to measure the level of drug-drug similarity. This paper proposes a computational method to measure drug-drug similarity using a novel source of evidence that is obtained from patient-centric data. More specifically, patients’ narration of their thoughts, opinions, and experience with drugs in social media are explored as a potential source to compute drug-drug similarity. Online healthcare communities were used to extract a dataset of patients’ reviews on anti-epileptic drugs. The collected dataset is preprocessed through Natural Language Processing (NLP) techniques and four text similarity methods are applied to measure the similarities among them. The obtained similarities are then used to generate drug-drug similarity-based ranking matrices which are analyzed through Pearson correlation, to answer questions related to the overall drug-drug similarity and the accuracy of the four similarity measures. To evaluate the obtained drug-drug similarities, they are compared with the corresponding ground-truth similarities obtained from DrugSimDB, a well-known drug-drug similarity tool that is based on drug-centric data. The results provide evidence on the feasibility of patient-centric data from social media as a novel source for computing drug-drug similarity.
format Online
Article
Text
id pubmed-9952733
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99527332023-02-25 Computing Drug-Drug Similarity from Patient-Centric Data Asiri, Yousef Bioengineering (Basel) Article In modern biology and medicine, drug-drug similarity is a major task with various applications in pharmaceutical drug development. Various direct and indirect sources of evidence obtained from drug-centric data such as side effects, drug interactions, biological targets, and chemical structures are used in the current methods to measure the level of drug-drug similarity. This paper proposes a computational method to measure drug-drug similarity using a novel source of evidence that is obtained from patient-centric data. More specifically, patients’ narration of their thoughts, opinions, and experience with drugs in social media are explored as a potential source to compute drug-drug similarity. Online healthcare communities were used to extract a dataset of patients’ reviews on anti-epileptic drugs. The collected dataset is preprocessed through Natural Language Processing (NLP) techniques and four text similarity methods are applied to measure the similarities among them. The obtained similarities are then used to generate drug-drug similarity-based ranking matrices which are analyzed through Pearson correlation, to answer questions related to the overall drug-drug similarity and the accuracy of the four similarity measures. To evaluate the obtained drug-drug similarities, they are compared with the corresponding ground-truth similarities obtained from DrugSimDB, a well-known drug-drug similarity tool that is based on drug-centric data. The results provide evidence on the feasibility of patient-centric data from social media as a novel source for computing drug-drug similarity. MDPI 2023-02-01 /pmc/articles/PMC9952733/ /pubmed/36829676 http://dx.doi.org/10.3390/bioengineering10020182 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Asiri, Yousef
Computing Drug-Drug Similarity from Patient-Centric Data
title Computing Drug-Drug Similarity from Patient-Centric Data
title_full Computing Drug-Drug Similarity from Patient-Centric Data
title_fullStr Computing Drug-Drug Similarity from Patient-Centric Data
title_full_unstemmed Computing Drug-Drug Similarity from Patient-Centric Data
title_short Computing Drug-Drug Similarity from Patient-Centric Data
title_sort computing drug-drug similarity from patient-centric data
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952733/
https://www.ncbi.nlm.nih.gov/pubmed/36829676
http://dx.doi.org/10.3390/bioengineering10020182
work_keys_str_mv AT asiriyousef computingdrugdrugsimilarityfrompatientcentricdata